|
ATCC
s aureus ccarm 3090 mrsa S Aureus Ccarm 3090 Mrsa, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/s aureus ccarm 3090 mrsa/product/ATCC Average 95 stars, based on 1 article reviews
s aureus ccarm 3090 mrsa - by Bioz Stars,
2026-03
95/100 stars
|
Buy from Supplier |
|
Charles River Laboratories
nf639 cells ![]() Nf639 Cells, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/nf639 cells/product/Charles River Laboratories Average 90 stars, based on 1 article reviews
nf639 cells - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: PLoS ONE
Article Title: Recombinant Lysyl Oxidase Propeptide Protein Inhibits Growth and Promotes Apoptosis of Pre-Existing Murine Breast Cancer Xenografts
doi: 10.1371/journal.pone.0031188
Figure Lengend Snippet: (A) Subcutaneous xenografts of NF639 breast cancer cells were injected once daily with 10 micrograms rLOX-PP for 5 days beginning on day 17 (arrows). Tumor volumes were monitored by caliper measurements (n = 10; *, p<0.05); (B) The tumor growth rates were determined from measurements made beginning on day 18 and were derived from linear regression analyses of the data. (C) Tumor weights at sacrifice on day 25 (p = 0.4, n = 10).
Article Snippet:
Techniques: Injection, Derivative Assay
Journal: PLoS ONE
Article Title: Recombinant Lysyl Oxidase Propeptide Protein Inhibits Growth and Promotes Apoptosis of Pre-Existing Murine Breast Cancer Xenografts
doi: 10.1371/journal.pone.0031188
Figure Lengend Snippet: (A) Subcutaneous 100 mm 3 xenografts of NF639 breast cancer cells were established in mice. rLOX-PP/alginate or empty beads were implanted on day 15 (arrow). Tumors were monitored by caliper measurements (n = 10; *, p<0.05, ***, p<0.01). (B) The tumor growth rates were determined from measurements made beginning on day 18 and were derived from linear regression analyses of the data; (C) tumor weights determined at sacrifice on day 25 (n = 10; *, p<0.05).
Article Snippet:
Techniques: Derivative Assay